Speaker illustration

Miss Emily Rosie Rolfe

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)

Identifying novel small molecule integrin agonists to mimic the favourable effects of the RGD domain of IGFBP-1 to treat cardiometabolic disease

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Drugs, Drug Targets

Session: Poster session 2

Thumbnail

ESC 365 is supported by